×

Subscribe Today

Get our free articles delivered directly to your email!

Continue reading

  • Gurus
  • Other
  • RA CAPITAL MANAGEMENT, L.P. (Data extracted from 13F, 13D, 13G and Form 4)

RA CAPITAL MANAGEMENT, L.P.

AUM: $11.32 B
13-F Portfolio Value: $8.12 B
Last 13-F Filed: Q3 2025
Concentration in top 10: 63.91%
Filter by:
Quarter to View:
Stock Company % Portfolio Shares Held Market Value Change in Shares % Change Quarter End Price Source
RYTMRHYTHM PHARMACEUTICALS INC7.05%5,681,359$573,760,445120,0002.16%$100.9913F
RNAAVIDITY BIOSCIENCES INC4.62%8,641,031$376,489,7211,375,00018.92%$43.5713F
CDTXCIDARA THERAPEUTICS, INC.4.39%3,372,923$357,496,1097,4000.22%13D
MLYSMINERALYS THERAPEUTICS INC3.41%7,323,750$277,716,6001,176,47019.14%$37.9213F
EWTXEDGEWISE THERAPEUTICS INC2.08%10,428,437$169,149,248525,8045.31%$16.2213F
WVEWave Life Sciences Ltd.1.51%18,231,824$121,970,90329,8150.16%Form 4
PEPGPEPGEN INC1.14%20,064,545$92,698,1989,375,00087.7%$4.6213F
LENZLENZ THERAPEUTICS, INC.1.13%4,265,106$91,571,82686,2832.06%13D
SRRKSCHOLAR ROCK HOLDING CORP0.53%1,166,788$43,451,18530,3352.67%$37.2413F
SLDBSOLID BIOSCIENCES INC0.44%5,811,423$35,856,4801000.00172%$6.1713F
JBIOJADE BIOSCIENCES, INC.0.36%3,214,969$29,191,9192,152,643202.63%13G
VORVOR BIOPHARMA INC.0.29%2,345,277$23,593,487362,97618.31%13D